VANCOUVER, British Columbia--(BUSINESS WIRE)-21. Okt. 2005--MIV Therapeutics, Inc. (OTCBB:MIVT) (FWB:MIV), ein Entwickler biokompatibler Stentbeschichtungen und Arzneistoffabgabesystemen der...
#42: MIVT News MIV Therapeutics Files both US and International Patents for Breakthrough Smart III Nanoparticle Drug Delivery System; Cutting-Edge Nanotechnology Particulate System Could Revolutionize Drug Delivery Methods to Treat Major Diseases
VANCOUVER, British Columbia--(BUSINESS WIRE)--Oct. 7, 2005--MIV Therapeutics, Inc. (OTCBB:MIVT)(Frankfurt/FSE:MIV), a developer of next-generation biocompatible stent coatings and drug delivery...
VANCOUVER, British Columbia--(BUSINESS WIRE)--Sept. 30, 2005--MIV Therapeutics, Inc. (OTCBB:MIVT)(Frankfurt/FSE:MIV), a developer of next-generation biocompatible stent coatings and drug delivery...
VANCOUVER, British Columbia - (BUSINESS WIRE) -Sept. 30, 2005--MIV Therapeutics, Inc. (OTCBB:MIVT)(Frankfurt/FSE:MIV), Entwickler von biokompatiblen Stentbeschichtungen und...
#39: MIVT News MIV Therapeutics Invests in Additional Equipment and Scientific Personnel In Reflection of R&D Program Expansion; Enhanced Infrastructure Designed to Accelerate Development of Unique HAp-Based Stent Coating and Drug Delivery Systems
VANCOUVER, British Columbia--(BUSINESS WIRE)--Sept. 28, 2005--MIV Therapeutics, Inc. (OTCBB:MIVT) (Frankfurt/FSE:MIV), a developer of next-generation biocompatible stent coatings and drug delivery...
#37: MIVT News MIV Therapeutics' Intellectual Property Portfolio Expands to 43 Patents, Patent Applications and Licenses on Novel Technologies; Aggressive IP Protection of Coating Technologies Positions Company for Entry into $100 Billion Drug-Delivery Market
VANCOUVER, British Columbia--(BUSINESS WIRE)--Sept. 26, 2005--MIV Therapeutics, Inc. (OTCBB:MIVT) (Frankfurt/FSE:MIV), a developer of next-generation biocompatible passive and drug-eluting stent...
VANCOUVER, British Columbia--(BUSINESS WIRE)-26. Sept. 2005--MIV Therapeutics, Inc. (OTCBB:MIVT) (Frankfurt/FSE:MIV), ein Entwickler biokompatibler und Arzneistoff-eluierender Stentbeschichtungen...
#36: MIVT News MIV Therapeutics Names Arc Rajtar to Post of Chief Technology Officer as Company Accelerates R&D Programs; Major Promotion Expands Oversight for Development of Proprietary HAp Biocompatible Drug-Eluting Medical Device Coatings
VANCOUVER, British Columbia--(BUSINESS WIRE)--Sept. 23, 2005--MIV Therapeutics, Inc. (OTCBB:MIVT), a developer of next-generation biocompatible passive and drug-eluting stent coatings and drug...
#35: MIVT News MIV Therapeutics Reaffirms Leadership in Advanced Biocompatible Stent Coating Technology at International Conference; Company Presents Next-Generation Coatings at 6th Pacific Rim Conference on Ceramics and Glass Technology
VANCOUVER, British Columbia--(BUSINESS WIRE)--Sept. 21, 2005--MIV Therapeutics, Inc. (OTCBB:MIVT), a developer of next-generation biocompatible stent coatings and drug delivery technologies, had an...
#33: MIVT News MIV Therapeutics präsentiert passive Stentbeschichtungen und Zwischenergebnisse aus Tierstudien mit proprietärer HAp-Beschichtung auf der TCT 2005, der weltgrößten Konferenz über kardiovaskuläre Therapien
VANCOUVER, British Columbia--(BUSINESS WIRE)-12. Sept. 2005-MIV Therapeutics, Inc. (OTCBB:MIVT), ein Entwickler biokompatibler und Arzneistoff-eluierender Stentbeschichtungen und von...
#34: MIVT News MIV Therapeutics' Passive Stent Coatings Accepted for Presentation at Prestigious World Conference on Cardiovascular Therapy; Interim Results of Animal Trials of Proprietary HAp Coating to be Detailed at TCT 2005 Conference
VANCOUVER, British Columbia--(BUSINESS WIRE)--Sept. 12, 2005--MIV Therapeutics, Inc. (OTCBB:MIVT), a developer of next-generation biocompatible stent coatings and drug delivery technologies for the...
VANCOUVER, British Columbia--(BUSINESS WIRE)--Sept. 2, 2005--MIV Therapeutics, Inc. (OTCBB:MIVT), a developer of next-generation biocompatible stent coatings and drug delivery technologies for the...
NEW YORK--(BUSINESS WIRE)--Sept. 2, 2005--(Investrend Research Syndicate) A research note on MIV Technologies, Inc. (OTCBB: MIVT) has been issued by Investrend Research Affiliate Beacon Equity...
#30: MIVT News MIV Therapeutics Further Expands IP Portfolio with Milestone Addition of Two New U.S. Provisional Patent Applications; Leading Biomedical Innovator Provides New Coating Technologies for Next Generation of Drug-Eluting Implantable Medical Devices
VANCOUVER, British Columbia--(BUSINESS WIRE)--Aug. 30, 2005--MIV Therapeutics, Inc. (OTCBB:MIVT), a developer of next-generation biocompatible passive and drug-eluting stent coatings and drug...
#29: MIVT News MIV Therapeutics Highlights Its Innovative Biomedical Technology in New Internet Presentation; Online Presentation Introduces Key Principles of Breakthrough HAp-Based Stent Coating Solutions
VANCOUVER, British Columbia--(BUSINESS WIRE)--Aug. 29, 2005--MIV Therapeutics, Inc. (OTCBB:MIVT), a developer of next-generation biocompatible stent coatings and drug delivery technologies, has...
